Attenuated response of myocardial flow reserve to lipid-lowering therapy with atorvastatin in patients with familial hypercholesterolemia.

被引:0
|
作者
Ishida, Y
Tsushima, M
Fukuchi, K
Miyake, Y
Sagoh, M
Oka, H
机构
[1] Natl Cardiovasc Ctr, Dept Radiol & Nucl Med, Suita, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Dept Cardiol, Suita, Osaka 565, Japan
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
171
引用
收藏
页码:54P / 54P
页数:1
相关论文
共 50 条
  • [21] Molecular diagnosis and combined lipid lowering therapy of heterozygous familial hypercholesterolemia.: Report of one case
    Arteaga, Antonio
    Cuevas, Ada
    Rigotti, Attilio
    Gonzalez, Francisco
    Castillo, Sergio
    Mata, Pedro
    Alonso, Rodrigo
    REVISTA MEDICA DE CHILE, 2007, 135 (02) : 216 - 220
  • [22] Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population
    Kadam, P.
    Ashavaid, T. F.
    Ponde, C. K.
    Rajani, R. M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 329 - 333
  • [23] Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy
    Miname, Marcio H.
    Bittencourt, Marcio Sommer
    Moraes, Sergio R.
    Alves, Romulo I. M.
    Silva, Pamela R. S.
    Jannes, Cinthia E.
    Pereira, Alexandre C.
    Krieger, Jose E.
    Nasir, Khurram
    Santos, Raul D.
    JACC-CARDIOVASCULAR IMAGING, 2019, 12 (09) : 1797 - 1804
  • [24] LIPID LOWERING THERAPY WITH STATINS IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    Korneva, V. A.
    Kuznetsova, T. Yu
    Tihova, G. P.
    KARDIOLOGIYA, 2019, 59 (03) : 27 - 35
  • [25] Reduction in Mortality in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in Lipid-Lowering Therapy
    Raal, Frederick J.
    Pilcher, Gillian J.
    Panz, Vanessa R.
    van Deventer, Hendrick E.
    Brice, Brigitte C.
    Blom, Dirk J.
    Marais, A. David
    CIRCULATION, 2011, 124 (20) : 2202 - 2207
  • [26] Familial Hypercholesterolemia in Children and Safety of Early Lipid-Lowering Treatment
    Bellunghi, Maria Sol
    Miname, Marcio
    Jannes, Cinthia E.
    Silva, Pamela R.
    Pereira, Alexandre
    Chacra, Ana Paula
    Salgado, Wilson
    Santos, Raul D.
    Rocha, Viviane Z.
    CIRCULATION, 2017, 136
  • [27] Tolerability and effects of high doses acipimox as additional lipid-lowering therapy in familial hypercholesterolemia
    Stuyt, PMJ
    Kleinjans, HAJ
    Stalenhoef, AFH
    NETHERLANDS JOURNAL OF MEDICINE, 1998, 53 (05): : 228 - 233
  • [28] Hypercholesterolemia - Is lipid-lowering worthwhile for older patients
    Deedwania, PC
    GERIATRICS-US, 2000, 55 (05): : 22 - +
  • [29] THERAPY OF HYPERCHOLESTEROLEMIA WITH MEVINOLIN AND OTHER LIPID-LOWERING DRUGS
    LEES, AM
    STEIN, SW
    LEES, RS
    CIRCULATION, 1986, 74 (04) : 200 - 200
  • [30] THERAPY OF HYPERCHOLESTEROLEMIA WITH MEVINOLIN AND OTHER LIPID-LOWERING DRUGS
    LEES, AM
    STEIN, SW
    LEES, RS
    ARTERIOSCLEROSIS, 1986, 6 (05): : A544 - A544